Slow Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.71M Sell
41,841
-1,705
-4% -$209K 0.67% 51
2026
Q1
$5.13M Buy
43,546
+1,946
+5% +$272K 0.67% 48
2025
Q4
$6.82M Sell
41,600
-2,476
-6% -$388K 0.81% 36
2025
Q3
$5.89M Buy
44,076
+8,511
+24% +$1.03M 0.69% 39
2025
Q2
$4.42M Buy
35,565
+2,688
+8% +$342K 0.54% 53
2025
Q1
$4.18M Buy
32,877
+16,117
+96% +$2.48M 0.56% 55
2024
Q4
$2.41M Buy
16,760
+534
+3% +$76.6K 0.34% 85
2024
Q3
$2.41M Buy
16,226
+61
+0.4% +$8.75K 0.37% 83
2024
Q2
$2.04M Buy
16,165
+1,558
+11% +$244K 0.33% 87
2024
Q1
$2.69M Buy
14,607
+348
+2% +$66.3K 0.43% 84
2023
Q4
$2.56M Buy
14,259
+267
+2% +$41.6K 0.45% 76
2023
Q3
$2.22M Buy
13,992
+2,223
+19% +$363K 0.41% 76
2023
Q2
$1.66M Sell
11,769
-338
-3% -$54.2K 0.29% 96
2023
Q1
$2.04M Buy
12,107
+362
+3% +$64.6K 0.38% 91
2022
Q4
$1.99M Buy
11,745
+735
+7% +$133K 0.44% 78
2022
Q3
$2.06M Buy
11,010
+8
+0.1% +$1.69K 0.45% 65
2022
Q2
$1.79M Buy
+11,002
New +$1.74M 0.43% 83

Other funds holding RGEN

Slow Capital's RGEN Position: Q2 2026 in Review

Slow Capital reduced its Repligen (RGEN) stake by 3.9% in Q2 2026, selling an estimated $209K and leaving 41,841 shares worth $5.71M. The position accounts for 0.67% of the portfolio, ranked #51.

Slow Capital first reported a position in RGEN in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.82M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Slow Capital held 41,841 shares of Repligen worth $5.71M as of Q2 2026.
  • Slow Capital sold 1,705 Repligen shares in Q2 2026, an estimated $209K.
  • Repligen made up 0.67% of Slow Capital's portfolio in Q2 2026, its #51 holding.
  • Slow Capital first reported a position in Repligen in Q2 2022 and has held it in 17 quarters since.
  • Slow Capital's Repligen position peaked at $6.82M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Slow Capital's 13F filing for Q2 2026, filed 22 Jul 2026.